Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...

The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

The authors compared outcomes among adults just under 70 years who were not prescribed Paxlovid to those who were given the ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

For a majority of people, the COVID vaccine doesn’t cause adverse health effects — but a small percentage experience chronic ...

A new analysis of health data from Ontario, Canada, suggests that nirmatrelvir-ritonavir (Paxlovid) may provide limited benefit for vaccinated older adults with COVID-19, despite its previously proven ...

Covid hospitalizations were not significantly reduced when adults used the antiviral pill, researchers find. Also, a nationwide study suggests estrogen may play a role in long covid, putting women at ...

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...